Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,745 DKK | -1.88% |
|
-3.38% | -19.03% |
06-28 | Would you like some more inflation? | ![]() |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.03% | 15.91B | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B | |
+116.20% | 10.8B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S, ProfoundBio - M&A Call